跳至主要内容
临床试验/NCT04449354
NCT04449354已完成不适用

A Study to Evaluate the HS Specific Wound Dressing HidraWear AX in the Home Setting

HidraMed Solutions Ltd1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2019年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
试验地点
1
主要终点
Ease of Use Day 21 vs Day 0

研究概览

简要总结

The product, HidraWear AX (www.hidrawear.com) is and adhesive free wound dressing system for the every day home care of Hidradenitis Suppurativa (HS), a debilitating disease of the skin for which there are limited wound dressing products.

This is a study to assess the use HidraWear Ax vs current product and method of use, and to determine the impact on patients' quality of life.

详细描述

The objective is to evaluate the ease of use of Hidrawear AX compared to the subject's existing product use in 23 subjects with HS (Hidradenitis Suppurativa).

Secondary objectives are to evaluate if Hidrawear AX:

  • Is comfortable
  • Improves quality of life
  • Faster to use than the subject's existing product
  • Reduces dressing related pain
  • Secure dressing retention

This pilot study will evaluate usability - the safety, efficacy and performance of HidraWear AX in the home setting. Quality of life, ease of use and comfort of Hidrawear AX will be assessed.

The clinical effect of the wound pad will not be assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Provision of signed and dated informed consent form in English.
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Female, aged >18
  • Diagnosed with Hidradenitis Suppurativa
  • Hidradenitis Suppurativa affecting the axilla
  • Exuding lesion that requires wound dressings

排除标准

  • Recent surgery <3 months in axilla
  • Psoriasis, Dermatitis or skin conditions/rash other than Hidradenitis Suppurativa on or near affected area
  • Pregnancy or lactation
  • Known allergic reactions to components of Hidrawear AX

结局指标

主要结局

Ease of Use Day 21 vs Day 0

时间窗: 3 weeks

10 point visual analogue scale with a maximum score of 10 and a minimum score of 0. self reported . A score of 0 means the product is very easy to use, and a score of 10 means the product is very difficult to use. A lower score represents a better outcome.

次要结局

  • Change in Quality of Life (QoL) Measured Using the Dermatology Life Quality Index (DLQI)(3 weeks)
  • Visual Pain Analogue Scale Day 21 vs Day 0(3 weeks)
  • Time Taken to Dress Wounds(3 weeks)
  • Body Image Visual Analogue Scale(3 weeks)
  • Patient Comfort(3 weeks)
  • Confidence in Dressing Product (Secure Retention, Leak Reduction)(3 weeks)

研究者

发起方
HidraMed Solutions Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验